Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 63
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for CRSP

Stock Name	Crispr Therapeutics AG
Ticker	CRSP(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	CH0334081137
LEI	506700O6IRRIQLT3W370

Show aggregate CRSP holdings

News associated with CRSP

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought: Growth stocks have been rallying in recent weeks, and that's usually great news for Cathie Wood. The founder, CEO, and stock-picking ace of the Ark Invest family of exchange-traded funds (ETFs) has momentum on her side. Her largest fund has soared nearly 30% since bottoming out l - 2025-05-08 15:22:00
Dimensional Fund Advisors LP Has $37.28 Million Stake in CRISPR Therapeutics AG (NASDAQ:CRSP): Dimensional Fund Advisors LP boosted its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 14.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 947,301 shares of the company’s stock after purchasing an additional 122,695 shares during the quarter. Dimensional […] - 2025-05-05 08:20:52
CRISPR Therapeutics AG (NASDAQ:CRSP) Given Consensus Rating of “Hold” by Analysts: Shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) have received an average rating of “Hold” from the twenty-one research firms that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, nine have given a hold recommendation and eleven have issued a buy recommendation on […] - 2025-05-02 07:20:50
CRISPR Therapeutics AG (NASDAQ:CRSP) Position Raised by NewEdge Advisors LLC: NewEdge Advisors LLC grew its position in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 28.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 7,420 shares of the company’s stock after purchasing an additional 1,622 shares during the quarter. NewEdge Advisors LLC’s […] - 2025-05-01 08:37:08
CRISPR Therapeutics AG (NASDAQ:CRSP) Shares Purchased by Invesco Ltd.: Invesco Ltd. raised its stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 6.3% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 33,790 shares of the company’s stock after purchasing an additional 2,010 shares during the period. Invesco Ltd.’s holdings in CRISPR […] - 2025-05-01 07:42:52
Raymond James Financial Inc. Invests $3.23 Million in CRISPR Therapeutics AG (NASDAQ:CRSP): Raymond James Financial Inc. bought a new position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 82,095 shares of the company’s stock, valued at approximately $3,231,000. A number of other institutional investors […] - 2025-04-28 07:51:03
Legal & General Group Plc Has $3.85 Million Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP): Legal & General Group Plc trimmed its position in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 8.5% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 97,804 shares of the company’s stock after selling 9,121 shares during the quarter. Legal & General […] - 2025-04-23 08:19:07
5 Monster Stocks -- Such as Coupang -- to Hold for the Next 10 Years: A "monster stock" might be one that frightens you by free-falling. Or it might alarm you with characteristics such as plummeting sales, shrinking profit margins, or surging debt. We'll use a different definition for this article. - 2025-04-20 13:15:00
Wells Fargo & Company MN Buys 17,094 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP): Wells Fargo & Company MN increased its stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 8.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 220,123 shares of the company’s stock after purchasing an additional 17,094 shares during the quarter. Wells Fargo & […] - 2025-04-18 07:36:51
Geode Capital Management LLC Sells 7,346 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP): Geode Capital Management LLC lessened its stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 0.7% in the 4th quarter, HoldingsChannel.com reports. The fund owned 1,000,868 shares of the company’s stock after selling 7,346 shares during the period. Geode Capital Management LLC’s holdings in CRISPR Therapeutics were worth $39,412,000 as of its […] - 2025-04-16 07:38:58
Peek Under The Hood: SMLF Has 42% Upside: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-08 11:18:44
Norges Bank Makes New $17.46 Million Investment in CRISPR Therapeutics AG (NASDAQ:CRSP): Norges Bank acquired a new position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 443,536 shares of the company’s stock, valued at approximately $17,458,000. Norges Bank owned about 0.52% of CRISPR Therapeutics as of its most recent filing with […] - 2025-04-08 08:19:03
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought: It's shaping up to be another rocky week of trading, and the volatility will probably keep Cathie Wood busy. The co-founder, CEO, and ace stock picker for Ark Invest tends to be active when the market's moving one way or another. She bought shares in four different companies acro - 2025-04-07 11:30:00
Mitsubishi UFJ Asset Management Co. Ltd. Raises Stock Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP): Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 7.6% in the fourth quarter, HoldingsChannel reports. The firm owned 5,252 shares of the company’s stock after buying an additional 372 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in CRISPR Therapeutics […] - 2025-04-04 08:12:57
KLP Kapitalforvaltning AS Buys New Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP): KLP Kapitalforvaltning AS purchased a new position in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) during the 4th quarter, HoldingsChannel reports. The institutional investor purchased 16,100 shares of the company’s stock, valued at approximately $634,000. A number of other large investors have also bought and sold shares of the stock. Charles Schwab Investment […] - 2025-04-03 07:28:56
Congress Wealth Management LLC DE Takes Position in CRISPR Therapeutics AG (NASDAQ:CRSP): Congress Wealth Management LLC DE purchased a new stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor purchased 5,640 shares of the company’s stock, valued at approximately $222,000. Several other hedge funds also recently added to or reduced their […] - 2025-03-31 08:15:00
Corient Private Wealth LLC Has $347,000 Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP): Corient Private Wealth LLC lessened its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 4.0% during the fourth quarter, HoldingsChannel.com reports. The firm owned 8,827 shares of the company’s stock after selling 365 shares during the period. Corient Private Wealth LLC’s holdings in CRISPR Therapeutics were worth $347,000 as of its most recent […] - 2025-03-31 07:30:54
Avantax Advisory Services Inc. Makes New Investment in CRISPR Therapeutics AG (NASDAQ:CRSP): Avantax Advisory Services Inc. acquired a new stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 6,836 shares of the company’s stock, valued at approximately $269,000. A number of other institutional investors have also modified their […] - 2025-03-26 08:50:59
Harbour Investments Inc. Sells 350 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP): Harbour Investments Inc. reduced its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 16.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,717 shares of the company’s stock after selling 350 shares during the period. Harbour Investments Inc.’s […] - 2025-03-24 08:39:11
Zurcher Kantonalbank Zurich Cantonalbank Has $874,000 Stock Position in CRISPR Therapeutics AG (NASDAQ:CRSP): Zurcher Kantonalbank Zurich Cantonalbank raised its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 3.0% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 22,217 shares of the company’s stock after acquiring an additional 645 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in CRISPR […] - 2025-03-21 09:18:55
Farther Finance Advisors LLC Acquires 977 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP): Farther Finance Advisors LLC boosted its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 34.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,834 shares of the company’s stock after purchasing an additional 977 shares during the period. Farther Finance […] - 2025-03-21 08:27:02
US Bancorp DE Sells 1,380 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP): US Bancorp DE lessened its holdings in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 53.3% during the 4th quarter, Holdings Channel reports. The firm owned 1,209 shares of the company’s stock after selling 1,380 shares during the period. US Bancorp DE’s holdings in CRISPR Therapeutics were worth $48,000 at the end of […] - 2025-03-19 07:10:48
CRISPR Therapeutics AG (NASDAQ:CRSP) Given Consensus Recommendation of “Hold” by Analysts: Shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) have been assigned a consensus recommendation of “Hold” from the twenty-one ratings firms that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and eleven have given a buy rating […] - 2025-03-13 06:53:04
BBMC's Underlying Holdings Could Mean 22% Gain Potential: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-03-06 12:34:24
3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.: Investors looking for growth in recent times have piled into stocks in artificial intelligence and quantum computing. But these aren't the only areas that offer the potential for explosive revenue growth and stock performance. Another industry also offers innovation and even gam - 2025-02-28 08:15:00
CRISPR Therapeutics AG (NASDAQ:CRSP) Shares Acquired by State of New Jersey Common Pension Fund D: State of New Jersey Common Pension Fund D boosted its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 10.8% during the 4th quarter, Holdings Channel reports. The fund owned 44,692 shares of the company’s stock after acquiring an additional 4,351 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings […] - 2025-02-26 08:31:02
CRISPR Therapeutics (NASDAQ:CRSP) Shares Down 4.7% Following Insider Selling: CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report)’s share price was down 4.7% during mid-day trading on Monday after an insider sold shares in the company. The stock traded as low as $45.16 and last traded at $45.65. Approximately 914,670 shares traded hands during mid-day trading, a decline of 62% from the average daily volume […] - 2025-02-26 06:24:52
Allworth Financial LP Purchases 14,398 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP): Allworth Financial LP lifted its position in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 2,117.4% during the fourth quarter, Holdings Channel.com reports. The firm owned 15,078 shares of the company’s stock after buying an additional 14,398 shares during the quarter. Allworth Financial LP’s holdings in CRISPR Therapeutics were worth $593,000 as of […] - 2025-02-21 08:38:56
Vontobel Holding Ltd. Trims Position in CRISPR Therapeutics AG (NASDAQ:CRSP): Vontobel Holding Ltd. trimmed its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 11.1% during the 4th quarter, Holdings Channel.com reports. The firm owned 15,068 shares of the company’s stock after selling 1,889 shares during the period. Vontobel Holding Ltd.’s holdings in CRISPR Therapeutics were worth $593,000 as of its most recent SEC […] - 2025-02-20 09:08:52
Citigroup Lowers CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $82.00: CRISPR Therapeutics (NASDAQ:CRSP – Free Report) had its target price decreased by Citigroup from $89.00 to $82.00 in a report released on Tuesday morning,Benzinga reports. Citigroup currently has a buy rating on the stock. Several other brokerages have also recently weighed in on CRSP. Needham & Company LLC reiterated a “buy” rating and set a […] - 2025-02-19 10:14:57

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) CRSP holdings

Date	Number of CRSP Shares Held	Base Market Value of CRSP Shares	Local Market Value of CRSP Shares	Change in CRSP Shares Held	Change in CRSP Base Value	Current Price per CRSP Share Held	Previous Price per CRSP Share Held
2025-05-07 (Wednesday)	40,847	USD 1,399,010	USD 1,399,010
2025-05-06 (Tuesday)	40,847	USD 1,354,487	USD 1,354,487
2025-05-05 (Monday)	40,847	USD 1,536,664	USD 1,536,664
2025-05-02 (Friday)	40,847	USD 1,562,398	USD 1,562,398	0	USD 21,241	USD 38.25	USD 37.73
2025-05-01 (Thursday)	40,847	USD 1,541,157	USD 1,541,157	0	USD -38,396	USD 37.73	USD 38.67
2025-04-30 (Wednesday)	40,847	USD 1,579,553	USD 1,579,553	0	USD 51,875	USD 38.67	USD 37.4
2025-04-29 (Tuesday)	40,847	USD 1,527,678	USD 1,527,678	0	USD -19,606	USD 37.4	USD 37.88
2025-04-28 (Monday)	40,847	USD 1,547,284	USD 1,547,284	0	USD -15,931	USD 37.88	USD 38.27
2025-04-25 (Friday)	40,847	USD 1,563,215	USD 1,563,215	0	USD -34,311	USD 38.27	USD 39.11
2025-04-24 (Thursday)	40,847	USD 1,597,526	USD 1,597,526	0	USD 23,283	USD 39.11	USD 38.54
2025-04-23 (Wednesday)	40,847	USD 1,574,243	USD 1,574,243	143	USD -22,575	USD 38.54	USD 39.23
2025-04-22 (Tuesday)	40,704	USD 1,596,818	USD 1,596,818	0	USD 57,393	USD 39.23	USD 37.82
2025-04-21 (Monday)	40,704	USD 1,539,425	USD 1,539,425	0	USD 2,035	USD 37.82	USD 37.77
2025-04-18 (Friday)	40,704	USD 1,537,390	USD 1,537,390	0	USD 0	USD 37.77	USD 37.77
2025-04-17 (Thursday)	40,704	USD 1,537,390	USD 1,537,390	0	USD -407	USD 37.77	USD 37.78
2025-04-16 (Wednesday)	40,704	USD 1,537,797	USD 1,537,797	0	USD -47,624	USD 37.78	USD 38.95
2025-04-15 (Tuesday)	40,704	USD 1,585,421	USD 1,585,421	0	USD 5,699	USD 38.95	USD 38.81
2025-04-14 (Monday)	40,704	USD 1,579,722	USD 1,579,722	0	USD -19,945	USD 38.81	USD 39.3
2025-04-11 (Friday)	40,704	USD 1,599,667	USD 1,599,667	0	USD 205,148	USD 39.3	USD 34.26
2025-04-10 (Thursday)	40,704	USD 1,394,519	USD 1,394,519	-1,144	USD -65,558	USD 34.26	USD 34.89
2025-04-09 (Wednesday)	41,848	USD 1,460,077	USD 1,460,077	0	USD 151,490	USD 34.89	USD 31.27
2025-04-08 (Tuesday)	41,848	USD 1,308,587	USD 1,308,587	-143	USD -51,082	USD 31.27	USD 32.38
2025-04-07 (Monday)	41,991	USD 1,359,669	USD 1,359,669	-143	USD -16,006	USD 32.38	USD 32.65
2025-04-04 (Friday)	42,134	USD 1,375,675	USD 1,375,675	-715	USD -89,332	USD 32.65	USD 34.19
2025-04-02 (Wednesday)	42,849	USD 1,465,007	USD 1,465,007	0	USD 44,991	USD 34.19	USD 33.14
2025-04-01 (Tuesday)	42,849	USD 1,420,016	USD 1,420,016	1,260	USD 4,742	USD 33.14	USD 34.03
2025-03-31 (Monday)	41,589	USD 1,415,274	USD 1,415,274	-423	USD -138,750	USD 34.03	USD 36.99
2025-03-28 (Friday)	42,012	USD 1,554,024	USD 1,554,024	0	USD -44,112	USD 36.99	USD 38.04
2025-03-27 (Thursday)	42,012	USD 1,598,136	USD 1,598,136	0	USD -47,894	USD 38.04	USD 39.18
2025-03-26 (Wednesday)	42,012	USD 1,646,030	USD 1,646,030	0	USD -71,841	USD 39.18	USD 40.89
2025-03-25 (Tuesday)	42,012	USD 1,717,871	USD 1,717,871	0	USD -72,680	USD 40.89	USD 42.62
2025-03-24 (Monday)	42,012	USD 1,790,551	USD 1,790,551	0	USD 58,816	USD 42.62	USD 41.22
2025-03-21 (Friday)	42,012	USD 1,731,735	USD 1,731,735	2,034	USD 85,841	USD 41.22	USD 41.17
2025-03-20 (Thursday)	39,978	USD 1,645,894	USD 1,645,894	0	USD -30,783	USD 41.17	USD 41.94
2025-03-19 (Wednesday)	39,978	USD 1,676,677	USD 1,676,677	0	USD 38,778	USD 41.94	USD 40.97
2025-03-18 (Tuesday)	39,978	USD 1,637,899	USD 1,637,899	0	USD -73,959	USD 40.97	USD 42.82
2025-03-17 (Monday)	39,978	USD 1,711,858	USD 1,711,858	0	USD 27,985	USD 42.82	USD 42.12
2025-03-14 (Friday)	39,978	USD 1,683,873	USD 1,683,873	-2,144	USD -84,830	USD 42.12	USD 41.99
2025-03-13 (Thursday)	42,122	USD 1,768,703	USD 1,768,703	0	USD -63,183	USD 41.99	USD 43.49
2025-03-12 (Wednesday)	42,122	USD 1,831,886	USD 1,831,886	0	USD 47,177	USD 43.49	USD 42.37
2025-03-11 (Tuesday)	42,122	USD 1,784,709	USD 1,784,709	0	USD -40,858	USD 42.37	USD 43.34
2025-03-10 (Monday)	42,122	USD 1,825,567	USD 1,825,567	0	USD -92,248	USD 43.34	USD 45.53
2025-03-07 (Friday)	42,122	USD 1,917,815	USD 1,917,815	-268	USD 81,904	USD 45.53	USD 43.31
2025-03-06 (Thursday)	42,390	USD 1,835,911	USD 1,835,911	0	USD -22,467	USD 43.31	USD 43.84
2025-03-05 (Wednesday)	42,390	USD 1,858,378	USD 1,858,378	0	USD 16,532	USD 43.84	USD 43.45
2025-03-04 (Tuesday)	42,390	USD 1,841,846	USD 1,841,846	-134	USD 43,506	USD 43.45	USD 42.29
2025-03-03 (Monday)	42,524	USD 1,798,340	USD 1,798,340	0	USD -69,314	USD 42.29	USD 43.92
2025-02-28 (Friday)	42,524	USD 1,867,654	USD 1,867,654	0	USD 12,757	USD 43.92	USD 43.62
2025-02-27 (Thursday)	42,524	USD 1,854,897	USD 1,854,897	0	USD -33,169	USD 43.62	USD 44.4
2025-02-26 (Wednesday)	42,524	USD 1,888,066	USD 1,888,066	0	USD -4,677	USD 44.4	USD 44.51
2025-02-25 (Tuesday)	42,524	USD 1,892,743	USD 1,892,743	268	USD -75,119	USD 44.51	USD 46.57
2025-02-24 (Monday)	42,256	USD 1,967,862	USD 1,967,862	0	USD -56,623	USD 46.57	USD 47.91
2025-02-21 (Friday)	42,256	USD 2,024,485	USD 2,024,485	0	USD -106,485	USD 47.91	USD 50.43
2025-02-20 (Thursday)	42,256	USD 2,130,970	USD 2,130,970	0	USD -109,443	USD 50.43	USD 53.02
2025-02-19 (Wednesday)	42,256	USD 2,240,413	USD 2,240,413	-134	USD 26,807	USD 53.02	USD 52.22
2025-02-18 (Tuesday)	42,390	USD 2,213,606	USD 2,213,606	0	USD 105,975	USD 52.22	USD 49.72
2025-02-17 (Monday)	42,390	USD 2,107,631	USD 2,107,631	0	USD 0	USD 49.72	USD 49.72
2025-02-14 (Friday)	42,390	USD 2,107,631	USD 2,107,631	0	USD 264,090	USD 49.72	USD 43.49
2025-02-13 (Thursday)	42,390	USD 1,843,541	USD 1,843,541	402	USD 25,461	USD 43.49	USD 43.3
2025-02-12 (Wednesday)	41,988	USD 1,818,080	USD 1,818,080	134	USD 159,825	USD 43.3	USD 39.62
2025-02-11 (Tuesday)	41,854	USD 1,658,255	USD 1,658,255	536	USD 29,913	USD 39.62	USD 39.41
2025-02-10 (Monday)	41,318	USD 1,628,342	USD 1,628,342	0	USD -12,396	USD 39.41	USD 39.71
2025-02-07 (Friday)	41,318	USD 1,640,738	USD 1,640,738	0	USD -37,186	USD 39.71	USD 40.61
2025-02-06 (Thursday)	41,318	USD 1,677,924	USD 1,677,924	0	USD -66,522	USD 40.61	USD 42.22
2025-02-05 (Wednesday)	41,318	USD 1,744,446	USD 1,744,446	0	USD 71,480	USD 42.22	USD 40.49
2025-02-04 (Tuesday)	41,318	USD 1,672,966	USD 1,672,966	0	USD 20,246	USD 40.49	USD 40
2025-02-03 (Monday)	41,318	USD 1,652,720	USD 1,652,720	0	USD -65,696	USD 40	USD 41.59
2025-01-31 (Friday)	41,318	USD 1,718,416	USD 1,718,416	0	USD -18,593	USD 41.59	USD 42.04
2025-01-30 (Thursday)	41,318	USD 1,737,009	USD 1,737,009	0	USD 34,294	USD 42.04	USD 41.21
2025-01-29 (Wednesday)	41,318	USD 1,702,715	USD 1,702,715	0	USD -24,791	USD 41.21	USD 41.81
2025-01-28 (Tuesday)	41,318	USD 1,727,506	USD 1,727,506	0	USD -1,652	USD 41.81	USD 41.85
2025-01-27 (Monday)	41,318	USD 1,729,158	USD 1,729,158	0	USD -64,870	USD 41.85	USD 43.42
2025-01-24 (Friday)	41,318	USD 1,794,028	USD 1,794,028	0	USD -33,467	USD 43.42	USD 44.23
2025-01-23 (Thursday)	41,318	USD 1,827,495	USD 1,827,495	0	USD 1,239	USD 44.23	USD 44.2
2025-01-22 (Wednesday)	41,318	USD 1,826,256	USD 1,826,256
2025-01-21 (Tuesday)	41,318	USD 1,715,110	USD 1,715,110
2025-01-20 (Monday)	41,318	USD 1,674,619	USD 1,674,619
2025-01-17 (Friday)	41,318	USD 1,674,619	USD 1,674,619
2025-01-16 (Thursday)	40,782	USD 1,643,515	USD 1,643,515
2025-01-15 (Wednesday)	40,246	USD 1,571,204	USD 1,571,204
2025-01-14 (Tuesday)	40,246	USD 1,543,837	USD 1,543,837
2025-01-13 (Monday)	40,246	USD 1,563,557	USD 1,563,557
2025-01-10 (Friday)	40,246	USD 1,597,364	USD 1,597,364
2025-01-09 (Thursday)	40,514	USD 1,672,823	USD 1,672,823
2025-01-09 (Thursday)	40,514	USD 1,672,823	USD 1,672,823
2025-01-09 (Thursday)	40,514	USD 1,672,823	USD 1,672,823
2025-01-08 (Wednesday)	40,514	USD 1,672,823	USD 1,672,823
2025-01-08 (Wednesday)	40,514	USD 1,672,823	USD 1,672,823
2025-01-08 (Wednesday)	40,514	USD 1,672,823	USD 1,672,823
2025-01-02 (Thursday)	41,050	USD 1,700,702	USD 1,700,702	0	USD 114,119	USD 41.43	USD 38.65
2024-12-30 (Monday)	41,050	USD 1,586,583	USD 1,586,583	-5,058	USD -657,954	USD 38.65	USD 48.68
2024-12-10 (Tuesday)	46,108	USD 2,244,537	USD 2,244,537	0	USD -53,486	USD 48.68	USD 49.84
2024-12-09 (Monday)	46,108	USD 2,298,023	USD 2,298,023	0	USD -114,809	USD 49.84	USD 52.33
2024-12-06 (Friday)	46,108	USD 2,412,832	USD 2,412,832	0	USD 130,025	USD 52.33	USD 49.51
2024-12-05 (Thursday)	46,108	USD 2,282,807	USD 2,282,807	0	USD -75,156	USD 49.51	USD 51.14
2024-12-04 (Wednesday)	46,108	USD 2,357,963	USD 2,357,963	0	USD -4,611	USD 51.14	USD 51.24
2024-12-03 (Tuesday)	46,108	USD 2,362,574	USD 2,362,574	0	USD -180,282	USD 51.24	USD 55.15
2024-12-02 (Monday)	46,108	USD 2,542,856	USD 2,542,856	0	USD 183,510	USD 55.15	USD 51.17
2024-11-29 (Friday)	46,108	USD 2,359,346	USD 2,359,346	0	USD 15,215	USD 51.17	USD 50.84
2024-11-28 (Thursday)	46,108	USD 2,344,131	USD 2,344,131	0	USD 0	USD 50.84	USD 50.84
2024-11-27 (Wednesday)	46,108	USD 2,344,131	USD 2,344,131	0	USD 70,546	USD 50.84	USD 49.31
2024-11-26 (Tuesday)	46,108	USD 2,273,585	USD 2,273,585	0	USD -50,258	USD 49.31	USD 50.4
2024-11-25 (Monday)	46,108	USD 2,323,843	USD 2,323,843	0	USD 116,192	USD 50.4	USD 47.88
2024-11-22 (Friday)	46,108	USD 2,207,651	USD 2,207,651	0	USD 73,312	USD 47.88	USD 46.29
2024-11-21 (Thursday)	46,108	USD 2,134,339	USD 2,134,339	0	USD -44,725	USD 46.29	USD 47.26
2024-11-20 (Wednesday)	46,108	USD 2,179,064	USD 2,179,064	0	USD 13,371	USD 47.26	USD 46.97
2024-11-19 (Tuesday)	46,108	USD 2,165,693	USD 2,165,693	0	USD -15,215	USD 46.97	USD 47.3
2024-11-18 (Monday)	46,108	USD 2,180,908	USD 2,180,908	-2,205	USD -270,010	USD 47.3	USD 50.73
2024-11-12 (Tuesday)	48,313	USD 2,450,918	USD 2,450,918	0	USD -42,999	USD 50.73	USD 51.62
2024-11-08 (Friday)	48,313	USD 2,493,917	USD 2,493,917	-147	USD -20,188	USD 51.62	USD 51.88
2024-11-07 (Thursday)	48,460	USD 2,514,105	USD 2,514,105	0	USD 56,214	USD 51.88	USD 50.72
2024-11-06 (Wednesday)	48,460	USD 2,457,891	USD 2,457,891	0	USD 17,445	USD 50.72	USD 50.36
2024-11-05 (Tuesday)	48,460	USD 2,440,446	USD 2,440,446	0	USD -11,145	USD 50.36	USD 50.59
2024-11-04 (Monday)	48,460	USD 2,451,591	USD 2,451,591	0	USD -8,239	USD 50.59	USD 50.76
2024-11-01 (Friday)	48,460	USD 2,459,830	USD 2,459,830	0	USD 211,771	USD 50.76	USD 46.39
2024-10-31 (Thursday)	48,460	USD 2,248,059	USD 2,248,059	0	USD -74,629	USD 46.39	USD 47.93
2024-10-30 (Wednesday)	48,460	USD 2,322,688	USD 2,322,688	0	USD -48,944	USD 47.93	USD 48.94
2024-10-29 (Tuesday)	48,460	USD 2,371,632	USD 2,371,632	0	USD -37,315	USD 48.94	USD 49.71
2024-10-28 (Monday)	48,460	USD 2,408,947	USD 2,408,947	0	USD 113,881	USD 49.71	USD 47.36
2024-10-25 (Friday)	48,460	USD 2,295,066	USD 2,295,066	0	USD -28,591	USD 47.36	USD 47.95
2024-10-24 (Thursday)	48,460	USD 2,323,657	USD 2,323,657	0	USD 94,497	USD 47.95	USD 46
2024-10-23 (Wednesday)	48,460	USD 2,229,160	USD 2,229,160	0	USD -98,858	USD 46	USD 48.04
2024-10-22 (Tuesday)	48,460	USD 2,328,018	USD 2,328,018	0	USD -22,777	USD 48.04	USD 48.51
2024-10-21 (Monday)	48,460	USD 2,350,795	USD 2,350,795	-148	USD -27,108	USD 48.51	USD 48.92
2024-10-18 (Friday)	48,608	USD 2,377,903	USD 2,377,903

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CRSP by Blackrock for IE00BDZVHG35

Show aggregate share trades of CRSP

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-04-23 BUY 143 38.540* 44.05
2025-04-10 SELL -1,144 34.260* 44.66 Profit of 51,093 on sale
2025-04-08 SELL -143 31.270* 44.93 Profit of 6,425 on sale
2025-04-07 SELL -143 32.380* 45.07 Profit of 6,446 on sale
2025-04-04 SELL -715 32.650* 45.22 Profit of 32,332 on sale
2025-04-01 BUY 1,260 33.140* 45.50
2025-03-31 SELL -423 34.030* 45.64 Profit of 19,305 on sale
2025-03-21 BUY 2,034 41.220* 46.10
2025-03-14 SELL -2,144 42.120* 46.40 Profit of 99,481 on sale
2025-03-07 SELL -268 45.530* 46.63 Profit of 12,497 on sale
2025-03-04 SELL -134 43.450* 46.78 Profit of 6,268 on sale
2025-02-25 BUY 268 44.510* 47.04
2025-02-19 SELL -134 53.020* 46.86 Profit of 6,279 on sale
2025-02-13 BUY 402 43.490* 46.70
2025-02-12 BUY 134 43.300* 46.77
2025-02-11 BUY 536 39.620* 46.92
2024-12-30 SELL -5,058 38.650* 49.50 Profit of 250,392 on sale
2024-11-18 SELL -2,205 47.300* 49.22 Profit of 108,526 on sale
2024-11-08 SELL -147 51.620* 48.94 Profit of 7,194 on sale
2024-10-21 SELL -148 48.510* 0.00
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-04-23	BUY	143	38.540*	44.05
2025-04-10	SELL	-1,144	34.260*	44.66 Profit of 51,093 on sale
2025-04-08	SELL	-143	31.270*	44.93 Profit of 6,425 on sale
2025-04-07	SELL	-143	32.380*	45.07 Profit of 6,446 on sale
2025-04-04	SELL	-715	32.650*	45.22 Profit of 32,332 on sale
2025-04-01	BUY	1,260	33.140*	45.50
2025-03-31	SELL	-423	34.030*	45.64 Profit of 19,305 on sale
2025-03-21	BUY	2,034	41.220*	46.10
2025-03-14	SELL	-2,144	42.120*	46.40 Profit of 99,481 on sale
2025-03-07	SELL	-268	45.530*	46.63 Profit of 12,497 on sale
2025-03-04	SELL	-134	43.450*	46.78 Profit of 6,268 on sale
2025-02-25	BUY	268	44.510*	47.04
2025-02-19	SELL	-134	53.020*	46.86 Profit of 6,279 on sale
2025-02-13	BUY	402	43.490*	46.70
2025-02-12	BUY	134	43.300*	46.77
2025-02-11	BUY	536	39.620*	46.92
2024-12-30	SELL	-5,058	38.650*	49.50 Profit of 250,392 on sale
2024-11-18	SELL	-2,205	47.300*	49.22 Profit of 108,526 on sale
2024-11-08	SELL	-147	51.620*	48.94 Profit of 7,194 on sale
2024-10-21	SELL	-148	48.510*	0.00

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CRSP

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-05-08	674,070	138	1,019,834	66.1%
2025-05-07	704,071	16,586	1,357,807	51.9%
2025-05-06	1,156,488	33,677	1,770,835	65.3%
2025-05-05	354,022	1,662	513,404	69.0%
2025-05-02	482,567	109	707,174	68.2%
2025-05-01	631,997	500	848,490	74.5%
2025-04-30	451,315	192	1,056,358	42.7%
2025-04-29	365,865	753	675,268	54.2%
2025-04-28	311,601	408	548,484	56.8%
2025-04-25	319,905	4,591	540,403	59.2%
2025-04-24	346,978	745	801,496	43.3%
2025-04-23	472,101	401	737,686	64.0%
2025-04-22	466,158	156	803,383	58.0%
2025-04-21	541,189	2,463	767,265	70.5%
2025-04-17	288,386	765	429,816	67.1%
2025-04-16	465,719	1,852	682,431	68.2%
2025-04-15	319,175	1,865	543,367	58.7%
2025-04-14	698,122	1,084	1,141,669	61.1%
2025-04-11	780,564	1,167	1,718,688	45.4%
2025-04-10	579,454	7,909	1,047,480	55.3%
2025-04-09	755,295	566	2,203,866	34.3%
2025-04-08	862,980	5,228	1,745,840	49.4%
2025-04-07	835,148	1,027	1,669,397	50.0%
2025-04-04	520,441	2,600	1,352,107	38.5%
2025-04-03	422,759	1,292	975,120	43.4%
2025-04-02	301,512	533	748,859	40.3%
2025-04-01	444,442	29,178	919,790	48.3%
2025-03-31	873,022	29,793	1,698,573	51.4%
2025-03-28	336,276	2,009	696,264	48.3%
2025-03-27	362,340	505	744,269	48.7%
2025-03-26	474,051	11,426	828,581	57.2%
2025-03-25	296,059	1,771	689,685	42.9%
2025-03-24	216,988	2,780	485,374	44.7%
2025-03-21	315,076	13,960	527,725	59.7%
2025-03-20	273,711	8,344	519,634	52.7%
2025-03-19	250,958	100	496,167	50.6%
2025-03-18	353,867	9,996	635,573	55.7%
2025-03-17	218,872	1,593	472,038	46.4%
2025-03-14	252,377	1,239	535,367	47.1%
2025-03-13	246,465	1,547	560,179	44.0%
2025-03-12	246,042	1,456	483,111	50.9%
2025-03-11	467,753	5,259	896,872	52.2%
2025-03-10	594,939	679	1,117,595	53.2%
2025-03-07	365,622	4,879	898,154	40.7%
2025-03-06	236,671	1,013	595,508	39.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE